Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
1h
Intellia Therapeutics: Promising Phase 2 Results and Attractive Valuation Spur Buy Recommendation
JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...
1d
Cautious Hold on Editas Medicine Amid Strategic Shifts and Financial Uncertainties
In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Hold rating on Editas Medicine (EDIT – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Accused of plagiarism
Oldest person in US dies
'Tarzan' star Ron Ely dies
Court orders new sentence
Courthouse attack charges
Grizzly bear fatally struck
DOJ warns Musk's PAC?
Reporter struck by shrapnel
Kristy now Category 4
Hikes annual pass prices
911 calls from rally released
Carbon removal firms report
Pneumococcal vax advice
Georgia repels cyberattack
Seeks WI ballot exit
To join Harris at rally
Unveils new AI rules
Sued by ‘ring boys’
Weekly jobless claims fall
Israeli strike on school
PA provisional ballot ruling
New lead dust standards
Georgia citizenship audit
Wins EU antitrust case
LA Times editor quits
$135 million in Gaza aid
US charges media tycoon
Philly synagogue targeted
Feedback